# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Clover Health Investments (NASDAQ:CLOV) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimat...
Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physicia...
- SEC Filing